Flick Randall P, Sprung Juraj, Gleich Stephen J, Barnes Roxann D, Warner David O, Dearani Joseph A, Scott Phillip D, Hanson Andrew C, Schroeder Darrell R, Schears Gregory J
Department of Anesthesiology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Paediatr Anaesth. 2008 Aug;18(8):757-66. doi: 10.1111/j.1460-9592.2008.02632.x.
We studied the association between the introduction of extracorporeal membrane oxygenation (ECMO) into routine practice and the survival of children who failed weaning from cardiopulmonary bypass (CPB). We compare two periods, before formal introduction of ECMO in our institution (1993-1999, pre-ECMO era) and after ECMO became a formalized program (2000-2006, ECMO era).
Retrospective review of Mayo Clinic Database between 1993 and 2006 for outcomes of patients <18 years old who required ECMO during repair of congenital heart malformations.
Thirty-five children during ECMO era received intraoperative ECMO, and 17 (54%) survived to hospital discharge. The frequency of ECMO use was the highest in neonates, therefore, this was the only subcohort of pediatric patients that allowed comparison of survival between the pre-ECMO and ECMO eras. When compared to pre-ECMO era, neonatal survival increased during ECMO era (P = 0.043). ECMO was mostly used in neonates with higher complexity of cardiac defects undergoing more complex repairs, and the overall improvement of survival was primarily due to better survival of these patients. During pre-ECMO era, survival was lower in patients with higher risk (P = 0.001). However, during ECMO era, no difference in survival was observed across assigned risk groups (P = 0.658).
The availability of ECMO for neonates failing to wean from CPB was associated with improved survival, especially in children undergoing repair of the most complex congenital heart malformations. After introduction of ECMO, survival improved and no longer depended upon the complexity of surgical repair.
我们研究了将体外膜肺氧合(ECMO)应用于常规治疗与心肺转流(CPB)撤机失败儿童的生存率之间的关联。我们比较了两个时期,即我们机构正式引入ECMO之前(1993 - 1999年,ECMO前时代)和ECMO成为正式项目之后(2000 - 2006年,ECMO时代)。
回顾梅奥诊所数据库1993年至2006年间<18岁先天性心脏畸形修复期间需要ECMO的患者的结局。
在ECMO时代,35名儿童接受了术中ECMO,其中17名(54%)存活至出院。ECMO的使用频率在新生儿中最高,因此,这是唯一可比较ECMO前和ECMO时代生存率的儿科患者亚组。与ECMO前时代相比,ECMO时代新生儿生存率有所提高(P = 0.043)。ECMO主要用于心脏缺陷更复杂且接受更复杂修复的新生儿,生存率的总体提高主要归因于这些患者更好的生存情况。在ECMO前时代,高风险患者的生存率较低(P = 0.001)。然而,在ECMO时代,各指定风险组的生存率未观察到差异(P = 0.658)。
CPB撤机失败的新生儿可使用ECMO与生存率提高相关,尤其是在接受最复杂先天性心脏畸形修复的儿童中。引入ECMO后,生存率提高且不再依赖于手术修复的复杂性。